Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Complex Mixtures
  • Grifola
  • Myelodysplastic Syndromes

abstract

  • Maitake was well tolerated. Enhanced in vitro neutrophil and monocyte function following treatment demonstrate that Maitake has beneficial immunomodulatory potential in MDS. Further study is warranted.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4317517

Digital Object Identifier (DOI)

  • 10.1007/s00262-014-1628-6

PubMed ID

  • 25351719

Additional Document Info

start page

  • 237

end page

  • 47

volume

  • 64

number

  • 2